By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Dharmacon, Inc. (Acquired By Fisher Scientific International) 

2650 Crescent Drive, Suite 100

Lafayette  Colorado  80026  U.S.A.
Phone: 303-604-9499-Or-800-235-9880 Fax: 303-604-9680




Company News
Lentigen Corporation And Dharmacon, Inc. Collaborate To Develop Custom Lentiviral Reagents For RNAi Research 8/30/2006 10:57:25 AM
Abbott Laboratories (ABT) And Dharmacon, Inc. Collaborate To Develop New siRNA-Based Therapeutics 7/6/2006 10:34:11 AM
Dharmacon, Inc. RNAi Global Initiative Members Advance Standards For Genome-Wide RNAi Research In Second Meeting 5/24/2006 12:22:48 PM
Fox Chase Cancer Center Joins Dharmacon, Inc. And International Research Institutes As Newest Member Of The Genome-Wide RNAi Global Initiative 4/4/2006 1:41:26 PM
Dharmacon, Inc. Release: RNAi Global Initiative Members Meet To Establish Collaboration And Accelerate Biomedical Discovery Using Genome-Wide siRNA Library 12/7/2005 11:20:17 AM
Dharmacon, Inc. And Alcon To Collaborate On Discovery Of New Therapies For Eye Diseases Using RNAi 10/20/2005 2:37:32 PM
Dharmacon, Inc. And 10 Leading Research Institutes Establish Global Initiative To Advance Research Using The World's First Human-Genome-Wide siRNA Library10/19/2005 5:13:18 PM
Cancer Research UK Adopts Dharmacon, Inc. Gene-Silencing Technology10/19/2005 5:13:04 PM
Dharmacon, Inc. Launches siARRAY RTF(TM) siRNA Libraries; First-Ever Using Reverse Transfection Technology10/19/2005 5:12:43 PM
Dharmacon, Inc. RNAi Technology Selected By Genentech, Inc. (DNA) To Support Drug Discovery Research10/19/2005 5:12:31 PM